Syringaldehyde Alleviates Cardiac Hypertrophy Induced by Hyperglycemia in H9c2 Cells Through GLP-1 Receptor Signals - Li, Yingxiao; Hsu, Chao-Tien; Yang, Ting-Ting; Cheng, Kai-Chun (Pharmaceuticals (Basel, Switzerland), 2025)
Keywords: Aldehydes; AMPK; Biomarkers; cardiac hypertrophy; Cardiomyocytes; Cardiomyopathy; Care and treatment; Cellular signal transduction; Complications and side effects; Diabetes; diabetes complications; Diabetic angiopathies; GLP-1 receptor agonists; GLP-1 resistance; Glucose; Health aspects; Heart attacks; Heart enlargement; Heart failure; Hyperglycemia; Kinases; O-linked N-acetylglucosamine transferase (OGT); Oxidative stress; Peptides; Physiology; Proteins; syringaldehyde; Testing; Taiwan; AMPK; O-linked N-acetylglucosamine transferase (OGT); syringaldehyde; diabetes complications; cardiac hypertrophy; GLP-1 resistance